梅州怀孕67天可以做人流吗-【梅州曙光医院】,梅州曙光医院,梅州人流手术医院,梅州那里做流产比较快,梅州怀孕多久之内都可以打胎,梅州乳房下垂纠正,梅州女子医院哪家好些,梅州妇科打胎需多少钱
梅州怀孕67天可以做人流吗梅州白带异常临床症状有哪些,梅州感冒咳嗽可以做人流吗,梅州怀孕多少天以后做打胎,梅州看盆腔炎多少钱,梅州治宫颈糜烂多少钱,梅州无痛的人流一般多少钱,梅州二个月做人流总价格
BEIJING, Aug. 1 (Xinhua) -- The after-tax CIF (cost, insurance and freight) price of China's jet fuel imports has been set at 7,768 yuan (1,206 U.S. dollars) per metric ton for August, China's economic planner said on Monday.The price adjustment marked the first time for the economic planner to adjust jet fuel prices on a monthly basis after it announced jet fuel pricing reforms in July, according to a notice posted on the National Development and Reform Commission (NDRC)'s website.The NDRC announced on July 7 that it would introduce a market-oriented jet fuel pricing mechanism starting from Aug. 1.Under the new mechanism, the ex-plant price of jet fuel is required to be no higher than the after-tax CIF price of jet fuel imports from Singapore, Asia's largest oil trading and storage center.Taking transportation expenses, trade volumes and international crude oil prices into account, the jet fuel premium is negotiable between jet fuel sellers and buyers and will be reviewed once a year, while jet fuel ex-plant prices will be adjusted on the first day of every month, according to the NDRC.
BEIJING, June 26 (Xinhua) -- A drama honoring an archivist who had devoted himself to the Chinese People's Liberation Army (PLA)'s archive work was staged Saturday evening in Beijing.The drama, "Sheng Ming Dang An," or "Archives of Life," tells the life story of Liu Yiquan who had worked as a file clerk and later a consultant at the PLA Archives for about 38 years.Liu had collected more than 830,000 pieces of military archives, which was regarded as a special contribution to the army. Li Changchun (L, front), a member of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee, congratulates actors on the successful performance of drama "life archives" in Beijing, capital of China, June 25, 2011.Despite being diagnosed with terminal cancer in 2008, Liu continued to work hard. He died on Jan. 28, 2010, at the age of 59.Li Changchun, a Standing Committee member of the Political Bureau of the Communist Party of China (CPC) Central Committee, joined the audience of the drama on Saturday.Li later said the drama was touching and significant in reflecting the model role of CPC members ahead of the 90th founding anniversary of the CPC.Liu Yiquan was also honored by the U.S. military authorities for his role in helping identify some key documents that led to the repatriation of the remains of the United States personnel who disappeared during and after the Korea War (1950-1953).
WASHINGTON, Sept. 14 (Xinhua) -- The U.S. space agency NASA unveiled plans on Wednesday for a deep space rocket to carry astronauts to the moon, Mars and other destinations beyond the International Space Station.The Space Launch System, or SLS, will be designed to carry the Orion Multipurpose Crew Vehicle, as well as important cargo, equipment and science experiments to Earth's orbit and destinations beyond. Additionally, the SLS will serve as a backup for commercial and international partner transportation services to the International Space Station."This launch system will create good-paying American jobs, ensure continued U.S. leadership in space, and inspire millions around the world," NASA Administrator Charles Bolden said in a statement. "President Obama challenged us to be bold and dream big, and that's exactly what we are doing at NASA. While I was proud to fly on the space shuttle, kids today can now dream of one day walking on Mars."The SLS rocket will incorporate technological investments from the Space Shuttle program and the Constellation program in order to take advantage of proven hardware and cutting-edge tooling and manufacturing technology that will significantly reduce development and operations costs.The first developmental flight, or mission, is targeted for the end of 2017, according to NASA.
LOS ANGELES, July 18 (Xinhua) -- U.S. scientists have proven that oncogenes can change normal cells into stem-like cells, paving the way to a safer and more practical approach to treating diseases like multiple sclerosis and cancer with stem cell therapy.In a collaborative study, researchers from the Keck School of Medicine of the University of Southern California (USC), and the Children's Hospital of Orange County (CHOC) in California and Good Samaritan Hospital Medical Center in New York have successfully converted human skin cells into brain cells by suppressing the expression of p53, a protein encoded by a widely studied oncogene. This suggests that p53 mutation helps determine cell fate -- good or bad -- rather than only the outcome of cancer.Oncogenes are generally thought to be genes that, when mutated, change healthy cells into cancerous tumor cells.Study findings were appearing Monday on the website of the American Association for the Advancement of Science (AAAS)."The reality may be more complicated than people think," said Jiang F. Zhong, Ph.D., assistant professor of pathology at the Keck School. "What is a stem cell gene? What is a cancer gene? It may be the same thing.""When you turn off p53, people think the cell becomes cancerous because we tend to focus on the bad thing," Zhong said. "Actually, the cell becomes more plastic and could do good things, too. Let's say the cell is like a person who loses his job (the restriction of p53). He could become a criminal or he could find another job and have a positive effect on society. What pushes him one way or the other, we don't know because the environment is very complicated."Stem cells can divide and differentiate into different types of cells in the body. In humans, embryonic stem cells differentiate into three families, or germ layers, of cells. The reasons why and how certain stem cells differentiate into particular layers are not clearly understood. However, from those layers, tissues and organs develop. The endoderm, for example, leads to formation of the stomach, colon and lungs, while the mesoderm forms blood, bone and heart tissue. In its study, Zhong's team examined human skin cells, which are related to brain and neural cells from the ectoderm.When p53 was suppressed, the skin cells developed into cells that looked exactly like human embryonic stem cells. But, unlike other man-made stem cells that are "pluripotent" and can become any other cells in the body, these cells differentiated only into cells from the same germ layer, ectoderm."IPSCs (induced pluripotent stem cells) can turn into anything, so they are hard to control," Zhong said. "Our cells are staying within the ectoderm lineage."Zhong said he expects that suppressing other oncogenes in other families of cells would have the same effect, which could have critical significance for stem cell therapy. Future research should focus on determining which genes to manipulate, Zhong said.The study is slated to appear in the Proceedings of the National Academy of Sciences later this month, according to AAAS.
BEIJING, Aug. 13 (Xinhua) -- The quality of the products China exported to the European Union (EU) improved during the first half of this year due to strict quality control measures, according to quality control authorities.The number of quality complaints made by the EU regarding Chinese imports declined by 45 percent in the first half of 2011, according to the General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ).The administration attributed the improved quality to its nationwide crackdown on counterfeited and substandard products.The administration launched a nationwide quality checkup in the first half of this year. Of the 4,815 batches of products that the quality control authorities checked between January and June, just 9.4 percent failed quality tests, 1.7 percentage points lower than that of the same period of last year, according to the administration.A total of 218,000 counterfeiting cases have been investigated so far this year, involving goods worth a total of 9.5 billion yuan (1.49 billion U.S. dollars), the administration said.